In recent trading session, Co-Diagnostics Inc (NASDAQ:CODX) saw 0.58 million shares changing hands at last check today with its beta currently measuring -0.82. Company’s recent per share price level of $1.48 trading at $0.23 or 18.00% at last check today assigns it a market valuation of $47.07M. That most recent trading price of CODX’s stock is at a discount of -50.68% from its 52-week high price of $2.23 and is indicating a premium of 33.78% from its 52-week low price of $0.98. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.74 million shares which gives us an average trading volume of 291.46K if we extend that period to 3-months.
Co-Diagnostics Inc (NASDAQ:CODX) trade information
Upright in the green today for gaining 18.00%, in the last five days CODX remained trading in the red while hitting it’s week-highest on Thursday, 08/29/24 when the stock touched $1.48 price level, adding 10.19% to its value on the day. Co-Diagnostics Inc’s shares saw a change of 10.90% in year-to-date performance and have moved -6.05% in past 5-day. Co-Diagnostics Inc (NASDAQ:CODX) showed a performance of 32.88% in past 30-days. Number of shares sold short was 0.3 million shares which calculate 3.53 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Wall Street analysts have assigned a consensus price target of 6 to the stock, which implies a rise of 75.33% to its recent value today. Analysts have been projecting 6 as a low price target for the stock while placing it at a high target of 6. It follows that stock’s current price would drop -305.41% in reaching the projected high whereas dropping to the targeted low would mean a loss of -305.41% for stock’s current value.
Co-Diagnostics Inc (CODX) estimates and forecasts
Statistics highlight that Co-Diagnostics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company added 28.26% of value to its shares in past 6 months, showing an annual growth rate of -2.50% while that of industry is 7.50. Apart from that, the company came lowering its revenue forecast for fiscal year 2024. This year revenue growth is estimated to fall -43.20% from the last financial year’s standing.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 370k for the same. And 1 analysts are in estimates of company making revenue of 370k in the next quarter. Company posted 2.46M and 3.56M of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -19.10% during past 5 years.
Co-Diagnostics Inc (NASDAQ:CODX)’s Major holders
Insiders are in possession of 5.40% of company’s total shares while institution are holding 15.31 percent of that, with stock having share float percentage of 16.18%. Investors also watch the number of corporate investors in a company very closely, which is 15.31% institutions for Co-Diagnostics Inc that are currently holding shares of the company. VANGUARD GROUP INC is the top institutional holder at CODX for having 1.78 million shares of worth $2.23 million. And as of 2024-06-30, it was holding 5.9689 of the company’s outstanding shares.
The second largest institutional holder is RENAISSANCE TECHNOLOGIES LLC, which was holding about 0.59 million shares on 2024-06-30. The number of shares represents firm’s hold over 1.967 of outstanding shares, having a total worth of $0.73 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 30, 2024, the former fund manager was holding 1.28 shares of worth $1.87 million or 4.01% of the total outstanding shares. The later fund manager was in possession of 444.78 shares on Jun 30, 2024, making its stake of worth around $0.65 million in the company or a holder of 1.39% of company’s stock.
